stride study semaglutide 🔴The trial! 👟⤵️ 🔹The STRIDE trial demonstrated that significantly improves function, symptoms, and health-related QoL in patients with symptomatic #cvPAD and T2DM STRIDE: GLP-1 Boosts Walking Capacity

Premenstrual Syndrome (PMS) Theres limited direct evidence that Ozempic changes PMS symptoms, but a recent clinical study suggests metabolic and reproductive hormone changes may influence them

The new era is proactive integrating biology, psychology, and technology to prevent disease before it starts

Addressing the high cost of weight loss medications is not only about economic fairness but also about promoting public health and well-being

Furthermore, in rat models, the GLP-1 RA exendin-4 was found to alleviate ischemiareperfusion injury in skin flaps by upregulating Gpx4 expression, thereby inhibiting ferroptosis [73]

Nat Rev Endocrinol 9 , 366376 (2013)